1-2 of 2
Maria Rozman
Close
Sort by
Journal Articles

CNL and aCML should be considered as a single entity based on molecular profiles and outcomes

Clinical Trials & Observations
Gonzalo Carreño-Tarragona, Alberto Álvarez-Larrán, Claire Harrison, José Carlos Martínez-Ávila, Juan Carlos Hernández-Boluda, Francisca Ferrer-Marín, Deepti H. Radia, Elvira Mora, Sebastian Francis, Teresa González-Martínez, Kathryn Goddard, Manuel Pérez-Encinas, Srinivasan Narayanan, José María Raya, Vikram Singh, Xabier Gutiérrez, Peter Toth, Paula Amat-Martínez, Louisa Mcilwaine, Magda Alobaidi, Karan Mayani, Andrew McGregor, Ruth Stuckey, Bethan Psaila, Adrián Segura, Caroline Alvares, Kerri Davidson, Santiago Osorio, Robert Cutting, Caroline P. Sweeney, Laura Rufián, Laura Moreno, Isabel Cuenca, Jeffery Smith, María Luz Morales, Rodrigo Gil-Manso, Ioannis Koutsavlis, Lihui Wang, Adam J. Mead, María Rozman, Joaquín Martínez-López, Rosa Ayala, Nicholas C. P. Cross
Journal: Blood Advances
Blood Adv (2023) 7 (9): 1672–1681.
https://doi.org/10.1182/bloodadvances.2022008204
Published: 2023
Includes: Supplemental data
Journal Articles

European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol

Alex Bataller, Ana Garrido, Francesca Guijarro, Guadalupe Oñate, Marina Diaz-Beyá, Montserrat Arnan, Mar Tormo, Susana Vives, María Paz Queipo de Llano, Rosa Coll, David Gallardo, Ferran Vall-Llovera, Lourdes Escoda, Antonio Garcia-Guiñon, Olga Salamero, Antònia Sampol, Brayan M. Merchan, Joan Bargay, Sandra Castaño-Díez, Daniel Esteban, Aina Oliver-Caldés, Andrea Rivero, Pablo Mozas, Mònica López-Guerra, Marta Pratcorona, Lurdes Zamora, Dolors Costa, Maria Rozman, Josep F. Nomdedéu, Dolors Colomer, Salut Brunet, Jorge Sierra, Jordi Esteve,
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1193–1206.
https://doi.org/10.1182/bloodadvances.2021005585
Published: 2022
Includes: Supplemental data